1. Home
  2. GKOS vs FN Comparison

GKOS vs FN Comparison

Compare GKOS & FN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$106.30

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Fabrinet

FN

Fabrinet

HOLD

Current Price

$455.24

Market Cap

14.9B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
FN
Founded
1998
1999
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Telecommunications Equipment
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
14.9B
IPO Year
2015
2010

Fundamental Metrics

Financial Performance
Metric
GKOS
FN
Price
$106.30
$455.24
Analyst Decision
Strong Buy
Buy
Analyst Count
13
7
Target Price
$122.08
$428.83
AVG Volume (30 Days)
1.2M
740.0K
Earning Date
10-29-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.80
EPS
N/A
9.70
Revenue
$469,820,000.00
$3,593,227,000.00
Revenue This Year
$30.89
$20.52
Revenue Next Year
$24.36
$15.38
P/E Ratio
N/A
$47.36
Revenue Growth
30.38
19.71
52 Week Low
$73.16
$148.55
52 Week High
$163.71
$498.00

Technical Indicators

Market Signals
Indicator
GKOS
FN
Relative Strength Index (RSI) 72.41 59.44
Support Level $93.78 $370.91
Resistance Level $97.22 $439.95
Average True Range (ATR) 4.67 26.03
MACD 1.69 0.40
Stochastic Oscillator 95.98 87.31

Price Performance

Historical Comparison
GKOS
FN

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About FN Fabrinet

Fabrinet provides advance-level optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advance optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advance-level of packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

Share on Social Networks: